ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
EU authorises intramuscular administration of Biogen’s Plegridy for MS
January 07, 2021A new intramuscular (IM) injection option of Biogen’s Plegridy (peginterferon beta-1a) has been approved by the European Commission for the treatment of relapsing-remitting multiple sclerosis (MS). -
CHMP recommends Biogen’s Plegridy and Avonex use in pregnancy
September 26, 2019The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the use of interferon beta therapies, including Biogen’s Plegridy and Avonex ...
Pharma Sources Insight January 2025
